STOCK TITAN

DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), has launched the MedShape® DynaNail Hybrid™ Fusion System, enhancing its foot and ankle product line. This innovative system combines dynamic compression with an easy insertion design, crucial for subsiding foot deformities through subtalar fusion surgery. The DynaNail Hybrid maintains compression throughout healing, utilizing an adaptive mechanism to ensure optimal bone contact. DJO emphasizes its commitment to advanced medical technology aimed at improving patient recovery times and outcomes.

Positive
  • Launch of the DynaNail Hybrid™ Fusion System enhances DJO's product line.
  • The system provides dynamic compression that is maintained during the healing process, crucial for effective bone fusion.
  • Designed with an easy insertion mechanism, catering to surgeons' needs for efficiency.
Negative
  • None.

Hybrid screw/nail design of the DynaNail Hybrid™ combines sustained dynamic compressive power with easy, intuitive insertion

DALLAS--(BUSINESS WIRE)-- DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced the launch of the MedShape® DynaNail Hybrid™ Fusion System. The latest addition to DJO’s robust suite of foot and ankle products and an expansion of the DynaNail Mini® line, the system leverages MedShape’s proven active, adaptive healing technology1 that maintains dynamic compression at the fusion site while offering an anatomically friendly design that simplifies insertion.

DJO MedShape DynaNail Hybrid Fusion System (Photo: Business Wire)

DJO MedShape DynaNail Hybrid Fusion System (Photo: Business Wire)

Subtalar fusion surgery is often performed to correct severe foot deformity or relieve pain. According to the Association for the Study of Internal Fixation Principles, applying compression across the fusion site is essential for promoting bone healing by maximizing bone-to-bone contact and limiting micromotion.2 Unlike other screws on the market that lose compression post-operatively, the DynaNail Hybrid maintains compression throughout the healing process to meet this need.3

“The active, adaptive healing provided by the DynaNail Hybrid truly embodies our mission of bringing cutting-edge, innovative technologies to patients that will get them back on their feet sooner and keep them active for longer,” said Gary Justak, President and General Manager of DJO Foot and Ankle. “The DynaNail Hybrid iterates on what’s tried and true – our dynamic materials technologies and straightforward, flexible instrumentation – but also offers a unique new anatomically friendly ‘hybrid’ design that’s simple to insert and powerful in maintaining compression.”

As its name suggests, the DynaNail Hybrid features a combined screw/nail design to provide today’s surgeons with a winning balance of ease and reliability. The threaded, screw-like tip complements bone anatomy and makes insertion easy, while the Distal Transverse Calcaneal Screw offers stability and prevents device migration, similar to a nail. Maintained active compression is provided through a proprietary Internal Superelastic NiTiNOL Element, which responds to up to 5 mm of bone settling or resorption at the healing site depending on implant length.2

Additionally, as a member of the DynaNail Mini® family, DynaNail Hybrid shares universal instrumentation and can be used in conjunction with DynaNail Mini for additional procedural versatility and flexibility.

“The DynaNail Hybrid provides the maintained active compression necessary for successful fusion in a package designed specifically to complement subtalar anatomy,” said Dr. Samuel Adams of Duke University Medical Center. “Not only can I implant with ease and efficiency, but the active, adaptive healing approach instills confidence that my patients will experience the best possible outcomes.”

For more information on the DynaNail Hybrid™ and the entire DynaNail Mini® family, please visit https://www.djoglobal.com/dynanail-hybrid.

About DJO®

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company's extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.

Dr. Samuel Adams is a paid consultant for DJO®.

References

1. https://www.djoglobal.com/our-brands/medshape/publications
2. Dupont KM, Shibuya N, Bariteau JT. Tibiotalocalcaneal Arthrodesis with Intramedullary Nails – Mechanobiological Background and Evolution of Compressive Technology. Global J Orthopedic Research, 2019. 1(5).
3. Data on File. Laboratory testing does not necessarily indicate clinical performance.

Ashley Brown

Ashley.Brown@djoglobal.com

512.348.9098

Source: DJO

FAQ

What is the DynaNail Hybrid Fusion System launched by DJO?

The DynaNail Hybrid Fusion System is a new product that combines dynamic compression with an easy insertion design, aimed at improving outcomes in subtalar fusion surgeries.

How does the DynaNail Hybrid benefit patients undergoing surgery?

It maintains active compression at the fusion site, which is essential for promoting healing and reducing pain post-surgery.

What company owns DJO and what is their stock symbol?

DJO is a subsidiary of Colfax Corporation, which trades on the NYSE under the stock symbol CFX.

Why is compression important in subtalar fusion surgery?

Compression maximizes bone-to-bone contact and limits micromotion, which is crucial for successful bone healing.

Who can benefit from the DynaNail Hybrid Fusion System?

Patients requiring subtalar fusion surgery, especially those with severe foot deformities or pain, can benefit from this innovative system.

CFX

:CFX

CFX Rankings

CFX Latest News

CFX Stock Data

2.10B
47.46M
4.71%
Specialty Industrial Machinery
Industrials
Link
United States
Wilmington